Ballantyne Therapeutics Overview
- Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$565K
Ballantyne Therapeutics General Information
Description
The company is currently operating under stealth mode.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Commercial Products
Other Industries
Other Services (B2C Non-Financial)
Other Consumer Durables
Other Commercial Services
Primary Office
- 7805 Pemswood Street
- Charlotte, NC 28277
- United States
+1 (704) 000-0000
Ballantyne Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Angel (individual) | 16-Oct-2015 | $565K | 00000 | Completed | Stealth |
Ballantyne Therapeutics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Michael Roberts Ph.D | Chief Executive Officer and Board Member |
Ballantyne Therapeutics Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brian Doxtator | Self | Board Member | 000 0000 |
| Donald Reynolds | Self | Board Member | 000 0000 |
| Michael Roberts Ph.D | Self | Chief Executive Officer and Board Member | 000 0000 |
| Simon Pedder Ph.D | Self | Board Member | 000 0000 |